Clinical trials
Recruiting Endocrine System Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
33 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 5 |
| 2025 | 5 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 33 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2 |
| McGill University | 2 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2 |
| Appalachian State University | 1 |
| Ascendis Pharma A/S | 1 |
| Ascendis Pharma Bone Diseases A/S | 1 |
| Biohaven Therapeutics Ltd. | 1 |
| C5 Biomedical | 1 |
| Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 1 |
| Cornell University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Endocrine System Diseases | 33 |
| Metabolic Diseases | 13 |
| Diabetes Mellitus | 10 |
| Glucose Metabolism Disorders | 9 |
| Autoimmune Diseases | 6 |
| Diabetes Mellitus, Type 1 | 6 |
| Diabetes Mellitus, Type 2 | 5 |
| Digestive System Neoplasms | 4 |
| Endocrine Gland Neoplasms | 4 |
| Neoplasms | 4 |
Trials
Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.